Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Active, Not Recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details
Active, Not Recruiting

SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.

NCT05020457

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
View Trial Details
Active, Not Recruiting

A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

NCT05485974

Conditions
Bronchial Neoplasms, Cancer, Cancer of Pancreas, +28 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas, California, United States
  • The Oncology Institute of Hope and Innovation Glendale, California, United States
  • The Oncology Institute of Hope and Innovation Long Beach, California, United States
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

NCT05163028

Conditions
Bronchial Neoplasms, Cancer, Cancer of Colon, +28 more
Locations
  • City of Hope Duarte, California, United States
  • California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • California Cancer Associates for Research and Excellence, Inc. (cCare) San Marcos, California, United States
View Trial Details
Active, Not Recruiting

SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial

NCT03306680

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • BC Cancer -Vancouver Island Vancouver, British Columbia, Canada
  • London Regional Cancer Program London, Ontario, Canada
  • Sunnybrook Odette Cancer Centre Toronto, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease

NCT03485378

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Alberta Health Services, Cross Cancer Institude Edmonton, Alberta, Canada
  • London Regional Cancer Program of the Lawson Health Research Institute London, Ontario, Canada
  • Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
  • UHN Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

NCT05653882

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • UCSD San Diego, California, United States
  • UCSF San Francisco, California, United States
View all 20 locations
View Trial Details

Related conditions